#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4190487	B	Proteolysis targeting chimera activity in human MCF7 cells assessed as induction of VHL-mediated delivery of ERRalpha for protein degradation by proteasome by measuring drug level causing 50% substrate depletion incubated for 24 hrs by Western blot method	Homo sapiens	1	ALA4190166	cell-based format	Scientific Literature
2.	ALA4190488	F	In vivo induction of ERRalpha degradation in CD-1 mouse heart at 100 mg/kg, ip every 8 hrs measured 5 hrs post last dose by LC/MS analysis relative to control	Mus musculus	1	ALA4190166	organism-based format	Scientific Literature
3.	ALA4190489	F	In vivo induction of ERRalpha degradation in CD-1 mouse kidney at 100 mg/kg, ip every 8 hrs measured 5 hrs post last dose by LC/MS analysis relative to control	Mus musculus	1	ALA4190166	organism-based format	Scientific Literature
4.	ALA4190490	F	In vivo induction of ERRalpha degradation in human MDA-MB-231 cells xenografted in CD-1 mouse at 100 mg/kg, ip every 8 hrs measured 5 hrs post last dose by LC/MS analysis relative to control	Homo sapiens	1	ALA4190166	organism-based format	Scientific Literature
5.	ALA4305574	B	Binding affinity to GST-tagged ERRalpha-LBD (unknown origin) using fluorescein-conjugated coactivator PGC-1alpha incubated for 1 hr by TR-FRET assay	Homo sapiens	20	ALA4304753	single protein format	Scientific Literature
6.	ALA4305576	B	Protac activity at VHL/ERRalpha in human MDA-MB-231 cells assessed as induction of ERalpha degradation at 30 nM incubated for 4 hrs by Western blot analysis relative to control	Homo sapiens	12	ALA4304753	cell-based format	Scientific Literature
7.	ALA4305578	B	Protac activity at VHL/ERRalpha in human MDA-MB-231 cells assessed as induction of ERalpha degradation at 100 nM incubated for 4 hrs by Western blot analysis relative to control	Homo sapiens	12	ALA4304753	cell-based format	Scientific Literature
8.	ALA4388596	B	Protac activity at VHL/ERRalpha in epoxomicin pre-treated human MCF7 cells assessed as induction of ERRalpha protein degradation incubated for 8 hrs by Western blot analysis	Homo sapiens	1	ALA4387721	cell-based format	Scientific Literature
9.	ALA4388597	B	Protac activity at VHL/ERRalpha in epoxomicin pre-treated human MCF7 cells assessed as induction of ERRalpha protein degradation at 1 uM incubated for 8 hrs by Western blot analysis relative to control	Homo sapiens	1	ALA4387721	cell-based format	Scientific Literature
10.	ALA5246301	B	Protac activity at VHL/ERRalpha in human MCF7 cells	Homo sapiens	1	ALA5244258	cell-based format	Scientific Literature
11.	ALA5246302	B	Protac activity at VHL/ERRalpha in human MCF7 cells assessed as maximum efficacy relative to control	Homo sapiens	1	ALA5244258	cell-based format	Scientific Literature
12.	ALA5246312	B	Protac activity at ER/VHL (unknown origin) degradation in human MCF7 cells by immunoblotting analysis	Homo sapiens	1	ALA5244258	cell-based format	Scientific Literature
13.	ALA5246313	B	Protac activity at ER/VHL (unknown origin) degradation in human MCF7 cells assessed as maximum efficacy by immunoblotting analysis relative to control	Homo sapiens	1	ALA5244258	cell-based format	Scientific Literature